Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Irati Erreguerena Redondo"'
Autor:
Gokce B. Laleci Erturkmen, Natassia Kamilla Juul, Irati Erreguerena Redondo, Ana Ortega Gil, Dolores Verdoy Berastegui, Esteban de Manuel, Mustafa Yuksel, Bunyamin Sarigul, Gokhan Yilmaz, Sarah N. L. I. M. Choi Keung, Theodoros N. Arvanitis, Thea Damkjaer Syse, Janika Bloemeke-Cammin, Rachelle Kaye, Anne Dichmann Sorknæs, on behalf of the ADLIFE study group
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 24, Iss 1, Pp 1-21 (2024)
Abstract Introduction This paper outlines the design, implementation, and usability study results of the patient empowerment process for chronic disease management, using Patient Reported Outcome Measurements and Shared Decision-Making Processes. Bac
Externí odkaz:
https://doaj.org/article/b92b76b5493b47bc80afa9e4e11f4988
Autor:
Joseba Igor Zabala, Irati Erreguerena Redondo, Igor Zabala Rementeria, Ana Porta Fernandez, Begoña Belarra Tellechea, Lucia Garate Echenique, Mª Puy Lopez Zabarte, Silvia Alfambra Vicente, Maria Olga Tellechea Rodriguez, Arrate Iraola Tapia, Arantxa Urruzola Lizarribar, Maria Remedios Vega Iñigo, Magdalena Cuesta Ortiz, Iraide Saduy Azcoaga, Nerea Aperribay Saez
Publikováno v:
International Journal of Integrated Care; Vol 22: Annual Conference Supplement 2022; 262
Introduction: Population aging and the increased number of chronic diseases push the healthcare systems to design and implement new strategies to improve the quality of services. These strategies require investment in ICT tools, promotion of patient
Autor:
Esteban Manuel Keenoy, Irati Erreguerena Redondo, Ane Fullaondo Zabala, María Dolores García Martínez, Ricardo Semper Ochotorena, Elena Valverde Bilbao, Carmela Mozo Avellaned, Manuel Vicente Carneiro, Ana Ortega-Gil
Publikováno v:
International Journal of Integrated Care; Vol 22: Annual Conference Supplement 2022; 166
Introduction: Population longevity, morbidity and high consumption of medicines, have become polypharmacy a priority health problem due to its high prevalence and problems that can cause: lack of adherence, increased adverse effects and drug interact